Close cardiovascular monitoring during the early stages of treatment for patients receiving immune checkpoint inhibitors

Bron
Pharmaceuticals - ISSN 1424-8247-17:7 (2024) p. 1-12
Auteur(s)

Extensive CArdioVAscular characterization and follow-up of patients receiving immune checkpoint inhibitors : a prospective multicenter study

Bron
Pharmaceuticals - ISSN 1424-8247-16:4 (2023) p. 1-14
Auteur(s)

First evidence of activity of enfortumab vedotin on brain metastases in urothelial cancer patients

Bron
Pharmaceuticals - ISSN 1424-8247-16:3 (2023) p. 1-8
Auteur(s)